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ABSTRACT 
Ginkgo biloba L. is the most commercialized medicinal plant worldwide, being its 
consumption related to prevention, and even decrease of the progression of degenerative 
neurological diseases. Considering the correlation between oxidative stress and the 
mentioned diseases, the antioxidant activity of different dietary supplements (syrup and 
several pills) was evaluated and compared to the leaves infusion, aqueous and 
methanolic extracts. Furthermore, G. biloba was chemically characterized in nutritional 
and bioactive components namely, fatty acids, sugars, organic acids, tocopherols, 
phenolics and flavonoids. Palmitic, α-linolenic and oleic acids were the main fatty acids 
found; fructose was the most abundant sugar; quinic acid was the most abundant 
organic acid and α-tocopherol was, by far, the most abundant vitamer. Dietary 
supplements showed higher antioxidant activity than G. biloba infusion and extracts due 
to their higher phenolics and flavonoids concentration. The pills with the highest 
concentration of plant extract (100 mg) allow the intake of the highest antioxidants 
concentration.  
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1. Introduction 
Ginkgo biloba L. (Ginkgoaceae) is an ancient tree growing in China for centuries; 
however, it was only during the last couple of decades that its true value was 
recognized, being considered sacred for its health-promoting properties (Smith et al., 
1996; Singh et al., 2008). 
The medical interest in western G. biloba has increased since the 1980s, due to its 
potent action on cardiovascular system and cerebral vascular activity. In recent decades, 
in Western countries, the concentrated extracts of the leaves have been marketed as 
herbal medicines due to the presence of bioactive components (e.g., terpenoids, 
polyphenols, organic acids, carbohydrates, essential fatty acids, inorganic salts and 
amino acids), and to the capacity to increase microcirculation in brain (with the supply 
of oxygen and nutrients) and in body extremities (Beek, 2002; Singh et al., 2008). Thus, 
it can be useful in the improvement of symptoms of poor memory, impaired mental 
concentration, particularly in the elderly, for whom this function is sometimes lowered. 
It also has positive effects in certain situations such as tinnitus (ringing) and hearing 
capacity altered, bringing also cardiovascular protection due to the ability to prevent 
platelet aggregation and thrombus formation.  Furthermore, due to the antioxidant 
properties it has been used in Alzheimer's patients (Smith et al., 1996; Diamond et al., 
2000; Beek and Montoro, 2009). 
Brain is particularly prone to damage by reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) due to five main reasons: the high oxygen required by this 
organ; the abundance of redox-active metals; the relative deficit in antioxidant systems; 
the presence of great amount of oxidizable polyunsaturated fatty acids and 
catecholamines; and the fact that neurons are post-mitotic cells with relatively restricted 
replacement by progenitor cells during lifetime (Mangialasche et al., 2009; Wang and 
Michaelis, 2010). 
Thus, a variety of mechanisms of neuronal degeneration in Alzheimer diseases has been 
proposed, including formation of free radicals, oxidative stress, mitochondrial 
dysfunction, inflammatory processes, genetic factors, environmental impact factors, 
apoptosis, among others (Zhi-you and Yong, 2007). Different studies reported that 
neuronal earliest changes and pathological features of this disease are related to 
oxidative damage (with a very high input of oxidative stress), mainly in the 
development of neuritic abnormalities. In fact, paired helical filaments are more often 
found in neurites with membrane abnormalities, which is indicative of extensive lipid 
peroxidation (Zhu et al., 2004; Zhi-you and Yong, 2007). Moreover, crosslinking of 
proteins by oxidative processes may lead to the resistance of the lesions to intracellular 
and extracellular removal even though when they are extensively ubiquitinated; this 
resistance of neurofibrillary tangles to proteolysis might play an important role in the 
progression of the degenerative disease (Zhu et al., 2004). In this context, the use of 
polyphenols may be useful, since they increase the cellular stress response and improve 
mitochondrial respiration, thus allowing the neuron to counteract free radical-induced 
damage and produce the ATP necessary to maintain the normal membrane potential 
(Mancuso et al., 2012). 
Taking into account the described relation between antioxidants and Alzheimer's 
disease, and considering the use of G. biloba in the mentioned pathology, the 
antioxidant activity of different dietary supplements (syrup and several pills) was 
evaluated and compared to the leaves infusion, aqueous and methanolic extracts. 
Furthermore, G. biloba was chemically characterized in nutritional and bioactive 
components. 
 2. Materials and methods 
2.1. Samples  
Ginkgo biloba dry leaves and dietary supplements (syrup and different pills based on 
leaves standardized extract with 24% glycosides and 6% terpenes) (Table 1) were 
obtained from an herbalist shop and a pharmacy, respectively, located in Bragança, 
Portugal.  
 
2.2. Standards and Reagents 
Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8% were of HPLC grade from 
Fisher Scientific (Lisbon, Portugal). The fatty acids methyl ester (FAME) reference 
standard mixture 37 (standard 47885-U) was purchased from Sigma (St. Louis, MO, 
USA), as also were other individual fatty acid isomers, L-ascorbic acid, tocopherols (α-, 
β-, γ-, and δ-isoforms), sugars (D(-)-fructose, D(+)-sucrose, D(+)-glucose, D(+)-
trehalose and D(+)-raffinose pentahydrate), trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), gallic acid and (+)-catechin standards. Racemic 
tocol, 50 mg/mL, was purchased from Matreya (PA, USA). 2,2-Diphenyl-1- 
picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, MA, USA). Water 
was treated in a Milli-Q water purification system (TGI Pure Water Systems, USA).  
 
2.3. Chemical characterization of Ginkgo biloba  
2.3.1. Macronutrients. G. biloba dry leaves were analysed for chemical composition 
(moisture, proteins, fat, carbohydrates and ash) using the AOAC procedures (AOAC, 
1995). The crude protein content (N × 6.25) of the samples was estimated by the macro-
Kjeldahl method; the crude fat was determined by extracting a known weight of 
powdered sample with petroleum ether, using a Soxhlet apparatus; the ash content was 
determined by incineration at 600±15 ºC. Total carbohydrates were calculated by 
difference.  
 
2.3.2. Free Sugars. Free sugars were determined by high performance liquid 
chromatography coupled to a refraction index detector (HPLC-RI), after an extraction 
procedure previously described by the authors (Rafael et al., 2011) using melezitoze as 
internal standard (IS). The equipment consisted of an integrated system with a pump 
(Knauer, Smartline system 1000), degasser system (Smartline manager 5000), auto-
sampler (AS-2057 Jasco) and a RI detector (Knauer Smartline 2300). Data were 
analysed using Clarity 2.4 Software (DataApex). The chromatographic separation was 
achieved with a Eurospher 100-5 NH2 column (4.6 × 250 mm, 5 mm, Knauer) operating 
at 30ºC (7971 R Grace oven). The mobile phase was acetonitrile/deionized water, 70:30 
(v/v) at a flow rate of 1 ml/min. The compounds were identified by chromatographic 
comparisons with authentic standards. Quantification was performed using the internal 
standard method and sugar contents were further expressed in g per 100 g of dry weight 
(dw). 
 
2.3.3. Organic acids. Organic acids were determined following a procedure previously 
described by the authors (Pereira et al., 2013a). The analysis was performed using a 
Shimadzu 20A series UFLC (Shimadzu Coperation). Separation was achieved on a 
SphereClone (Phenomenex) reverse phase C18 column (5 µm, 250 mm × 4.6 mm i.d) 
thermostatted at 35 ºC.  The elution was performed with sulphuric acid 3.6 mM using a 
flow rate of 0.8 mL/min. Detection was carried out in a PDA, using 215 nm and 245 nm 
(for ascorbic acid) as preferred wavelengths. The organic acids found were quantified 
by comparison of the area of their peaks recorded at 215 nm with calibration curves 
obtained from commercial standards of each compound. The results were expressed in g 
per 100 g of dry weight (dw).  
 
2.3.4. Fatty acids. Fatty acids were determined by gas–liquid chromatography with 
flame ionization detection (GC-FID)/capillary column as described previously by the 
authors (Rafael et al., 2011). The analysis was carried out with a DANI model GC 1000 
instrument equipped with a split/splitless injector, a flame ionization detector (FID at 
260 ºC) and a Macherey–Nagel column (30 m x 0.32 mm ID x 0.25 μm df). The oven 
temperature program was as follows: the initial temperature of the column was 50 ºC, 
held for 2 min, then a 30 ºC/min ramp to 125 ºC, 5 ºC/min ramp to 160 ºC, 20 ºC/ min 
ramp to 180 ºC, 3 ºC/min ramp to 200 ºC, 20 ºC/min ramp to 220 ºC and held for 15 
min. The carrier gas (hydrogen) flow-rate was 4.0 ml/min (0.61 bar), measured at 50 ºC. 
Split injection (1:40) was carried out at 250 ºC. Fatty acid identification was made by 
comparing the relative retention times of FAME peaks from samples with standards. 
The results were recorded and processed using the CSW 1.7 Software (DataApex 1.7) 
and expressed in relative percentage of each fatty acid. 
 
2.3.5. Tocopherols. Tocopherols were determined following a procedure previously 
described by the authors (Rafael et al., 2011). Analysis was performed by HPLC 
(equipment described above), and a fluorescence detector (FP-2020; Jasco) programmed 
for excitation at 290 nm and emission at 330 nm. The chromatographic separation was 
achieved with a Polyamide II (250 x 4.6 mm) normal-phase column from YMC Waters 
operating at 30ºC. The mobile phase used was a mixture of n-hexane and ethyl acetate 
(70:30, v/v) at a flow rate of 1 mL/min, and the injection volume was 20 µL. The 
compounds were identified by chromatographic comparisons with authentic standards. 
Quantification was based on the fluorescence signal response of each standard, using 
the IS (tocol) method and by using calibration curves obtained from commercial 
standards of each compound. The results were expressed in mg per 100 g of dry weight 
(dw).  
 
2.4. Evaluation of antioxidant properties of Ginkgo biloba extracts and dietary 
supplements 
2.4.1. Samples preparation. The samples were prepared as indicated in the label: For 
infusion preparation, 2 g of powdered dry leaves were added to 200 mL of boiling 
distilled water, left to stand at room temperature for 10 min, and then filtered under 
reduced pressure, frozen, lyophilized and redissolved in distilled water at a final 
concentration of 20 mg/mL; for dietary supplements, one pill was dissolved in distilled 
water. Information regarding the plant weight in each pill, destilled water volumes and 
final concentrations of the prepared solutions is provided in Table 1. Methanolic and 
aqueous extracts were also prepared from the dry leaves, stirring 1 g with 30 mL 
methanol or water, respectively, at 25 ºC at 150 rpm for 1 h and filtered through 
Whatman No. 4 paper. The residues were then extracted with one additional 30 mL 
portion of the corresponding solvent. The combined extracts were evaporated under 
reduced pressure (rotary evaporator Büchi R-210; Flawil, Switzerland) and re-dissolved 
in the corresponding solvent at 20 mg/mL. 
Several dilutions of all the prepared solutions were used in the antioxidant activity 
assays. 
 
2.4.2. Phenolics and flavonoids content. Total phenolics were estimated by Folin-
Ciocalteu colorimetric assay according to procedures previously described (Guimarães 
et al., 2009) and the results were expressed as mg of gallic acid equivalents (GAE) per g 
of sample. 
Total flavonoids were determined by a colorimetric assay using aluminum trichloride, 
following procedures previously reported (Barros et al., 2010); the results were 
expressed as mg of (+)-catechin equivalents (CE) per g of sample. 
 
2.4.3. DPPH radical-scavenging activity. This methodology was performed using an 
ELX800 microplate Reader (Bio-Tek Instruments, Inc; Winooski, USA). The reaction 
mixture on 96 well plate consisted in the sample solutions (30 µL) and methanolic 
solution (270 µL) containing DPPH radicals (6×10-5 mol/L). The mixture was left to 
stand for 30 min in the dark, and the absorption was measured at 515 nm (Barros et al., 
2010). The radical scavenging activity (RSA) was calculated as a percentage of DPPH 
discoloration using the equation: %RSA=[(ADPPH-AS)/ADPPH]×100, where AS is the 
absorbance of the solution containing the sample, and ADPPH is the absorbance of the 
DPPH solution. The results were expressed in EC50 values (sample concentration 
providing 50% of radical scavenging activity). Trolox was used as positive control. 
 
2.4.4. Reducing power. The sample solutions (0.5 mL) were mixed with sodium 
phosphate buffer (200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 
0.5 mL). The mixture was incubated at 50 °C for 20 min, and trichloroacetic acid (10% 
w/v, 0.5 mL) was added. The mixture (0.8 mL) was poured in the 48 wells plate, the 
same with deionised water (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL), and the 
absorbance was measured at 690 nm in the Microplate Reader mentioned above (Barros 
et al., 2010). The results were expressed in EC50 values (sample concentration providing 
0.5 of absorbance). Trolox was used as positive control. 
 
2.4.5. Inhibition of β-carotene bleaching. A solution of β-carotene was prepared by 
dissolving β-carotene (2 mg) in chloroform (10 mL). Two milliliters of this solution 
were pipetted into a round-bottom flask. The chloroform was removed at 40 °C under 
vacuum and linoleic acid (40 mg), Tween 80 emulsifier (400 mg), and distilled water 
(100 mL) were added to the flask with vigorous shaking. Aliquots (4.8 mL) of this 
emulsion were transferred into test tubes containing sample solutions (0.2 mL). The 
tubes were shaken and incubated at 50 °C in a water bath. As soon as the emulsion was 
added to each tube, the zero time absorbance was measured at 470 nm (Barros et al., 
2010). β-Carotene bleaching inhibition was measured by the formula: β-carotene 
absorbance after 2h/initial absorbance) × 100. The results were expressed in EC50 values 
(sample concentration providing 50% of antioxidant activity). Trolox was used as 
positive control. 
 
2.4.6. TBARS assay. Porcine (Sus scrofa) brains were obtained from official slaughtered 
animals, dissected, and homogenized with Polytron in an ice cold Tris-HCl buffer (20 
mM, pH 7.4) to produce a 1:2 w/v brain tissue homogenate which was centrifuged at 
3000g for10 min. An aliquot (100 µL) of the supernatant was incubated with the sample 
solutions (200 µL) in the presence of FeSO4 (10 mM; 100 µL) and ascorbic acid 
(0.1mM; 100 µl) at 37 °C for 1h. The reaction was stopped by the addition of 
trichloroacetic acid (28% w/v, 500 µL), followed by thiobarbituric acid (TBA, 2%, w/v, 
380 µL), and the mixture was then heated at 80 °C for 20 min. After centrifugation at 
3000g for 10 min to remove the precipitated protein, the color intensity of the 
malondialdehyde (MDA)-TBA complex in the supernatant was measured by its 
absorbance at 532 nm (Barros et al., 2010). The inhibition ratio (%) was calculated 
using the following formula: Inhibition ratio (%) = [(A−B)/A] × 100%, where A and B 
were the absorbance of the control and the sample solution, respectively. The results 
were expressed in EC50 values (sample concentration providing 50% of lipid 
peroxidation inhibition). Trolox was used as positive control. 
 
2.5. Statistical analysis 
For each formulation, three samples were used and all the assays were carried out in 
triplicate. The results were expressed as mean values and standard deviation (SD). The 
results were analyzed using one-way analysis of variance (ANOVA) followed by 
Tukey’s HSD Test with α = 0.05. This treatment was carried out using SPSS v. 18.0 
program.  
 
3. Results and Discussion 
3.1. Chemical characterization of Ginkgo biloba  
The nutritional value of G. biloba leaves was evaluated, and the results are given in 
Table 2. Carbohydrates, calculated by difference, were the most abundant 
macronutrients (72.98 g/100 g dw). Otherwise, fat was the macronutrient present in 
lower amount, which confers a more healthy character to this medicinal plant (4.75 
g/100 g dw). The levels of proteins and ash were 12.27 and 10.01 g/100 g dw, 
respectively.   
Chemical composition in fatty acids, sugars, organic acids and tocopherols was also 
accessed and the results are shown in Table 3.  
Palmitic (C16:0), α-linolenic (C18:3n3) and oleic (C18:1n9) acids were the most 
abundant fatty acids (35.90, 18.03 and 11.18%, respectively). The latter is nowadays 
considered as the preferred fatty acid for edible purposes, because it combines a 
hypocholesterolemic effect and a high oxidative stability (Mensink and Katan, 1989). In 
general, saturated fatty acids appeared in higher concentrations (59.15%), followed by 
polyunsaturated (28.85%) and lastly monounsaturated fatty acids (12%).  
The sugars found were fructose, glucose and sucrose, being fructose (1.42 g/100 g dw) 
the main one and sucrose the least abundant sugar (0.23 g/100 g dw).  
Oxalic, quinic, malic and shikimic acids were also identified and quantified, being 
quinic acid the most abundant organic acid (2.26 g/100 g dw). This acid is a very useful 
and versatile chiral pool starting material for natural product synthesis and many groups 
have developed elegant syntheses based on stereoselective reactions of quinic acid 
derivatives (Murray et al., 2004). Shikimic acid is also present in high quantity (2.24 
g/100 g dw); it is used as key starting material for the synthesis of the neuramidase 
inhibitor GS4104 for treatment of antiviral infections (Krämer et al., 2003).  On the 
other hand, malic acid was the organic acid found in lower quantity. 
Regarding tocopherols, the isoforms α-, β-, γ- and δ- tocopherol were all detected. α-
Tocopherol was, by far, the most abundant vitamer (124.88 mg/100 g dw in a total of 
126.23 mg/100 g dw). Considering its antioxidant potential and various functions at the 
molecular level, this vitamer reduces the risk of cardiovascular diseases (eliminating 
reactive oxygen species, inhibiting lipid peroxidation and attenuating inflammatory 
reactions) and neurodegenerative disorders, particularly in Alzheimer's disease (Burton, 
1994; Berman and Brodaty, 2004; Kontush and Schekatolina, 2004).  
As far as we know, the present study is pioneer regarding chemical characterization of 
G. biloba in nutritional molecules, which is important considering that it is widely 
consumed as infusion and incorporated in dietary supplements. 
 
3.2. Antioxidant properties of Ginkgo biloba extracts and dietary supplements 
The antioxidant properties of different dietary supplements based on G. biloba (syrup 
and pills) and of extracts prepared from the leaves (infusion, methanolic and aqueous 
extracts) were compared. Dietary supplements showed higher antioxidant activity than 
extracts prepared from the dry leaves (Table 4). Among dietary supplements, pills gave 
higher antioxidant activity than syrup. Furthermore, it was observed an increase of 
antioxidant properties with the increase of G. biloba extract concentration in the pills. In 
fact, P3 (with 100 mg G. biloba standardized extract) was better than P2 (with 60 mg G. 
biloba standardized extract), and this one better than P1 (with 40 mg G. biloba 
standardized extract), for all the tested assays. The same behavior was observed for 
bioactive components namely, phenolics and flavonoids; the samples with highest 
antioxidant activity also gave the highest contents of the mentioned compounds, which 
pointed out for an involvement of phenolics and flavonoids in the observed activity. 
Our research group reported opposing results in a study with Cynara scolymus L. 
(artichoke), Silybum marianum (L.) Gaertn (milk thistle) and Cochlospermum 
angolensis Welw. (borututu), in which infusions showed higher antioxidant activity 
than dietary supplements (Pereira et al., 2013b). This could be attributed to the very low 
amounts of phenolics found in those dietary supplements (3.35 to 30.70 mg GAE/g) in 
comparison with the ones obtained in the present study for G. biloba syrup and pills 
(396.98 to 553.41 mg GAE/g). 
Regarding the extracts prepared from the dry leaves, methanolic extract (LME) showed 
higher DPPH radical scavenging activity, reducing power and lipid peroxidation 
inhibition, measured by β-carotene bleaching and TBARS inhibition. It also gave higher 
phenolics and flavonoids content than infusion or aqueous extract; a decrease in 
bioactive compounds was observed in infusion in comparison with aqueous extracts 
probably related to a degradation caused by heat. According to other authors, phenolic 
compounds are unstable and easily became non-antioxidative under heating and in the 
presence of antioxidants; thus, heat could destroy the structures of polyphenols and 
cause a decrease in their antioxidant activity (Yen and Hung, 2000). 
 
Overall, dietary supplements containing plant extracts are complex mixtures whose 
therapeutic effect is often attributed to the cumulative effects of several components 
with bioactive properties. Thus, it is important to have an overview of all the elements 
present to evaluate product quality at nutraceutical and nutritional level. Particularly in 
G. biloba plant, several bioactive compounds were identified and quantified, such as 
tocopherols, mainly α-tocopherol, and phenolic compounds (potent antioxidants with an 
active role in relation to reducing the risk of atherosclerosis and attenuating neurological 
damage in patients with Alzheimer's disease). G. biloba pills (mainly P3, the dietary 
supplement with the highest concentration of plant extract) allow the intake of the 
highest antioxidants concentration.  
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 Table 1. Information about the studied Ginkgo biloba samples. 
 
 
Code Sample Composition Mode of consumption (minimal dose/day) Concentration of the prepared solution  
LI 
Plant 
Dry leaves Infusion 20 mg/mL 
LME Methanolic extract from dry leaves - 20 mg/mL 
LAE Aqueous extract from dry leaves - 20 mg/mL 
S Syrup 40 mg of Ginkgo biloba standardized extracta /mL 1 mL diluted in a glass of water (200 mL);  2 or 3 times 200 µg/mL 
P1 
Pills  
40 mg of Ginkgo biloba standardized extracta/pill 1 pill dissolved in ½ glass of water (100 mL); 2 or 3 times 400 µg/mL 
P2 60 mg of Ginkgo biloba standardized extracta/pill  1 pill dissolved in a glass of water (200 mL); 2 times 300 µg/mL 
P3 100 mg of Ginkgo biloba standardized extracta/pill 1 pill dissolved in a large glass of water (350 mL); 1 time 286 µg/mL 
 
aCorresponds to G. biloba leaves extract with 24% glycosides and 6% terpenes (information available in the label).  
Therapeutic indications: Antioxidant properties, antiasthmatic, scavenge radicals, wound healing and neuroprotective properties as well as it improves mental capacities in 
Alzheimer's patients. 
 
 
 
  
Table 2. Nutritional value of Ginkgo biloba dry leaves. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
dw- dry weight 
Parameter Amount 
Ash  10.01 ± 0.06 g/100 g dw 
Proteins  12.27 ± 0.24 g/100 g dw 
Fat  4.75 ± 0.22 g/100 g dw 
Carbohydrates  72.98 ± 0.20 g/100 g dw 
Table 3. Individual compounds present in Ginkgo biloba dry leaves. 
 
 
SFA- Saturated fatty acids; MUFA- Monounsaturated fatty acids; PUFA- 
Polyunsaturated fatty acids; dw- dry weight. 
 
Fatty acids (relative percentage) Free sugars (g/100 g dw) 
C6:0 0.24 ± 0.01 Fructose  1.42 ± 0.05 
C8:0 0.27 ± 0.04  Glucose  0.78 ± 0.01 
C10:0 0.24 ± 0.01 Sucrose  0.23 ± 0.02 
C12:0 0.61 ± 0.09  Total  2.43 ± 0.04 
C14:0 6.13 ± 0.47 Organic acids (g/100 g dw) 
C15:0 0.68 ± 0.03 Oxalic acid 0.90 ± 0.00 
C16:0 35.90 ± 0.97 Quinic acid 2.26 ± 0.09 
C16:1 0.82 ± 0.12 Malic acid 0.58 ± 0.01 
C17:0 1.28 ± 0.02 Shikimic acid 2.24 ± 0.01 
C18:0 4.17 ± 0.24 Total  5.98 ± 0.10 
C18:1n9 11.18 ± 1.23 Tocopherols (mg/100 g dw) 
C18:2n6c 10.53 ± 0.09 α-Tocopherol 124.88 ± 0.37 
C18:3n3 18.03 ± 0.06 β-Tocopherol 0.36 ± 0.03 
C20:0 2.70 ± 0.05 γ-Tocopherol 0.72 ± 0.06 
C20:3n6 0.11 ± 0.07 δ-Tocopherol 0.28 ± 0.01 
C20:3n3+C21:0 0.19 ± 0.08 Total  126.23 ± 0.47 
C22:0 2.19 ± 0.01   
C23:0 0.92 ± 0.00   
C24:0 3.82 ± 0.04   
SFA 59.15 ± 1.39   
MUFA 12.00 ± 1.35   
PUFA 28.85 ± 0.04   
Table 4. Phenolics, flavonoids and antioxidant properties of Ginkgo biloba extracts and dietary supplements. 
 
 LI LME LAE S P1 P2 P3 
Phenolics  
(mg GAE/g) 
37.71 ± 0.04g 129.5 ± 5.30e 61.58 ± 0.53f 461.45 ± 5.75c 396.98 ± 4.84d 501.86 ± 4.24b 553.41 ± 1.19a 
Flavonoids 
(mg CE/g) 
1.53 ± 0.01f 14.87 ± 0.84d 1.39 ± 0.32f 5.89 ± 0.90e 28.30 ± 1.61c 47.89 ± 0.55b 53.21 ± 0.59a 
DPPH scavenging activity 
(EC50, mg/mL) 
1.52 ± 0.17a 0.74 ± 0.04b 1.58 ± 0.05a 0.14 ± 0.00cd 0.18 ± 0.01c 0.11 ± 0.01cd 0.07 ± 0.01d 
Reducing power  
(EC50, mg/mL) 
0.83 ± 0.02a 0.36 ± 0.01c 0.73 ± 0.00b 0.14 ± 0.00d 0.13 ± 0.00e 0.08 ± 0.00f 0.06 ± 0.00g 
β-carotene bleaching inhibition  
(EC50, mg/mL) 
4.71 ± 0.35a  4.47 ± 0.08b 4.85 ± 0.10a 0.47 ± 0.05c 0.56 ± 0.07 c 0.43 ± 0.03c 0.22 ± 0.02d 
TBARS inhibition  
(EC50, mg/mL)  
1.29 ± 0.18a 0.13 ± 0.01cd 0.82 ± 0.09b 0.24 ± 0.06c 0.12 ± 0.01de 0.03 ± 0.00de 0.02 ± 0.01e 
LI- infusion prepared from dry leaves; LME- methanolic extract prepared from dry leaves; LAE- aqueous extract prepared from dry leaves; S- syrup; 
P- pills. EC50 values correspond to the sample concentration achieving 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. 
GAE- gallic acid equivalents; CE- catechin equivalents. In each row different letters mean significant differences (p<0.05). 
 
